Literature DB >> 29948516

Differences in smoking prevalence and eligibility for low-dose computed tomography (LDCT) lung cancer screening among older U.S. adults: role of sexual orientation.

Alicia K Matthews1, Sean Esteban McCabe2, Joseph G L Lee3, Phil Veliz2.   

Abstract

The purpose of this study was to determine the past-year prevalence estimates of cigarette smoking and eligibility for low-dose computed tomography (LDCT) lung cancer screening among older U.S. adults and examine potential variations in these estimates by sexual orientation. Data were from the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III) and included in-person interviews with a nationally representative sample of non-institutionalized adults aged 18 and older. Eligibility for LDCT was based on U.S. Centers for Medicare and Medicaid Services (CMS) guidelines. Analyses included participants aged 55-77 (n = 9,635). Overall, 17.5% of older adult respondents reported past-year smoking. Overall rates of past-year cigarette smoking were influenced by sex and sexual orientation with males reporting higher rates compared to females. Among both males and females, smoking was most prevalent among bisexual individuals. Eligibility for LDCT was also higher among males compared to females and among bisexually identified adults relative to homosexual and heterosexual-identified adults. Overall, 11.2% of older U.S. adults met eligibility for LDCT lung cancer screening. Eligibility for LDCT lung screening is associated with sexual orientation; the highest rates of eligibility are among bisexual women and men (26.9 and 24.5%, respectively). The current study found variations in cigarette smoking and eligibility for LDCT lung cancer screening (a proxy for chronic high-risk smoking) among older U.S. adults based on sexual orientation. Efforts to increase screening should take into account these differences.

Entities:  

Keywords:  Cancer disparities; Cancer screening; Cigarette smoking; LDCT lung cancer screening; Sexual orientation

Mesh:

Year:  2018        PMID: 29948516      PMCID: PMC6045449          DOI: 10.1007/s10552-018-1044-x

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  20 in total

1.  Advanced statistics: up with odds ratios! A case for odds ratios when outcomes are common.

Authors:  Thomas D Cook
Journal:  Acad Emerg Med       Date:  2002-12       Impact factor: 3.451

2.  Transgender Use of Cigarettes, Cigars, and E-Cigarettes in a National Study.

Authors:  Francisco O Buchting; Kristen T Emory; Yoonsang Kim; Pebbles Fagan; Lisa E Vera; Sherry Emery
Journal:  Am J Prev Med       Date:  2017-01-13       Impact factor: 5.043

3.  Prevalence, sociodemographic correlates and DSM-5 substance use disorders and other psychiatric disorders among sexual minorities in the United States.

Authors:  Bradley T Kerridge; Roger P Pickering; Tulshi D Saha; W June Ruan; S Patricia Chou; Haitao Zhang; Jeesun Jung; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2016-11-07       Impact factor: 4.492

Review 4.  Promotion of tobacco use cessation for lesbian, gay, bisexual, and transgender people: a systematic review.

Authors:  Joseph G L Lee; Alicia K Matthews; Cramer A McCullen; Cathy L Melvin
Journal:  Am J Prev Med       Date:  2014-11-18       Impact factor: 5.043

5.  Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals.

Authors:  Gita Suneja; Meredith S Shiels; Sharon K Melville; Melanie A Williams; Ramesh Rengan; Eric A Engels
Journal:  AIDS       Date:  2013-01-28       Impact factor: 4.177

Review 6.  Cancer treatment and survivorship statistics, 2014.

Authors:  Carol E DeSantis; Chun Chieh Lin; Angela B Mariotto; Rebecca L Siegel; Kevin D Stein; Joan L Kramer; Rick Alteri; Anthony S Robbins; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-06-01       Impact factor: 508.702

7.  Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

8.  Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.

Authors:  Harry J de Koning; Rafael Meza; Sylvia K Plevritis; Kevin ten Haaf; Vidit N Munshi; Jihyoun Jeon; Saadet Ayca Erdogan; Chung Yin Kong; Summer S Han; Joost van Rosmalen; Sung Eun Choi; Paul F Pinsky; Amy Berrington de Gonzalez; Christine D Berg; William C Black; Martin C Tammemägi; William D Hazelton; Eric J Feuer; Pamela M McMahon
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

Review 9.  Impact of tobacco control interventions on socioeconomic inequalities in smoking: review of the evidence.

Authors:  Sarah Hill; Amanda Amos; David Clifford; Stephen Platt
Journal:  Tob Control       Date:  2013-09-17       Impact factor: 7.552

10.  Is it getting better? An analytical method to test trends in health disparities, with tobacco use among sexual minority vs. heterosexual youth as an example.

Authors:  Yuko Homma; Elizabeth Saewyc; Bruno D Zumbo
Journal:  Int J Equity Health       Date:  2016-05-23
View more
  3 in total

1.  LDCT lung cancer screening eligibility and use of CT scans for lung cancer among sexual minorities.

Authors:  Philip Veliz; Alicia K Matthews; Cynthia Arslanian-Engoren; Rebecca J Evans-Polce; Joseph G L Lee; Carol J Boyd; Tonda Hughes; Vita V McCabe; Sean Esteban McCabe
Journal:  Cancer Epidemiol       Date:  2019-03-23       Impact factor: 2.984

2.  Preliminary Evaluation of a Citizen Scientist Educational Curriculum Aimed at Engaging Black Men in Lung Cancer Early Detection Screening.

Authors:  Alicia K Matthews; Marcus Murray; Josef Ben Levi; David Odell; Rohan Jeremiah; LeAndre Moore; Damilola Oyaluade; Alexis Chappel; Larisa Burke; Karriem Watson
Journal:  Am J Mens Health       Date:  2022 May-Jun

3.  Sexual Orientation, Tobacco Use, and Tobacco Cessation Treatment-Seeking: Results From a National U.S. Survey.

Authors:  Sean Esteban McCabe; Brady T West; Alicia K Matthews; Rebecca Evans-Polce; Joseph G L Lee; Tonda L Hughes; Phil Veliz; Vita McCabe; Carol J Boyd
Journal:  Behav Med       Date:  2020-07-23       Impact factor: 3.104

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.